These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12052143)

  • 21. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer.
    Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I
    Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes.
    Grant DM; Blum M; Beer M; Meyer UA
    Mol Pharmacol; 1991 Feb; 39(2):184-91. PubMed ID: 1996083
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic polymorphism in N-Acetyltransferase (NAT): Population distribution of NAT1 and NAT2 activity.
    Walker K; Ginsberg G; Hattis D; Johns DO; Guyton KZ; Sonawane B
    J Toxicol Environ Health B Crit Rev; 2009; 12(5-6):440-72. PubMed ID: 20183529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacogenomics of arylamine N-acetyltransferases--from drug metabolism to drug discovery.
    Sim E
    Pharmacogenomics; 2002 Nov; 3(6):729-31. PubMed ID: 12437474
    [No Abstract]   [Full Text] [Related]  

  • 25. Neonatal ontogeny of murine arylamine N-acetyltransferases: implications for arylamine genotoxicity.
    McQueen CA; Chau B
    Toxicol Sci; 2003 Jun; 73(2):279-86. PubMed ID: 12700401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Polymorphism of N-acetyltransferase-2 and pathogenesis of neoplastic diseases].
    Kłodowska-Duda GA; Samelska JA; Opala GM
    Wiad Lek; 2005; 58(3-4):212-7. PubMed ID: 16119167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
    Wang H; Liu L; Hanna PE; Wagner CR
    Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impairment of the activity of the xenobiotic-metabolizing enzymes arylamine N-acetyltransferases 1 and 2 (NAT1/NAT2) by peroxynitrite in mouse skeletal muscle cells.
    Dairou J; Dupret JM; Rodrigues-Lima F
    FEBS Lett; 2005 Aug; 579(21):4719-23. PubMed ID: 16098511
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cloning and molecular characterization of three arylamine N-acetyltransferase genes from Bacillus anthracis: identification of unusual enzymatic properties and their contribution to sulfamethoxazole resistance.
    Pluvinage B; Dairou J; Possot OM; Martins M; Fouet A; Dupret JM; Rodrigues-Lima F
    Biochemistry; 2007 Jun; 46(23):7069-78. PubMed ID: 17511472
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human N-acetyltransferases and drug-induced hepatotoxicity.
    Makarova SI
    Curr Drug Metab; 2008 Jul; 9(6):538-45. PubMed ID: 18680474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arylamine N-acetyltransferases: structural and functional implications of polymorphisms.
    Sim E; Lack N; Wang CJ; Long H; Westwood I; Fullam E; Kawamura A
    Toxicology; 2008 Dec; 254(3):170-83. PubMed ID: 18852012
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detoxification enzymes: cellular metabolism and susceptibility to various diseases.
    Silva M; Carvalho MDG
    Rev Assoc Med Bras (1992); 2018 Apr; 64(4):307-310. PubMed ID: 30133607
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo and in vitro metabolism of arylamine procarcinogens in acetyltransferase-deficient mice.
    Sugamori KS; Brenneman D; Grant DM
    Drug Metab Dispos; 2006 Oct; 34(10):1697-702. PubMed ID: 16815960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic basis of toxic reactions to drugs and chemicals.
    Cascorbi I
    Toxicol Lett; 2006 Mar; 162(1):16-28. PubMed ID: 16310984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in N-acetyltransferase research: 7th international workshop on N-acetyltransferases (NAT): workshop report.
    Lichter J; Golka K; Sim E; Blömeke B
    Arch Toxicol; 2017 Jul; 91(7):2715-2718. PubMed ID: 28331975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug acetylator phenotypes in newborn infants.
    Szórády I; Sánta A; Veress I
    Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis of hepatic enzyme activities of drug metabolizing enzymes-phenotyping and genotyping].
    Ozawa S
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1999; (117):63-76. PubMed ID: 10859937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in NAT2 gene and atherosclerosis in an Algerian population.
    Khelil M; Zenati A; Makrelouf M; Otmane A; Tayebi B
    Arch Med Res; 2010 Apr; 41(3):215-20. PubMed ID: 20682180
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolism of xenobiotics and chemical carcinogenesis.
    Lang M; Pelkonen O
    IARC Sci Publ; 1999; (148):13-22. PubMed ID: 10493245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Arylamine N-acetyltransferases - of mice, men and microorganisms.
    Upton A; Johnson N; Sandy J; Sim E
    Trends Pharmacol Sci; 2001 Mar; 22(3):140-6. PubMed ID: 11239577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.